Mylan NV Ord Shs (MYL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYL | AGN | TEVA | BHC | RDY |
| Company | Mylan NV Ord Shs | Allergan Plc | Teva Pharmaceutical Industries ADR | Bausch Health Companies Inc | Dr. Reddy's Laboratories Ltd ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 15.64 | 193.01 | 13.24 | 8.80 | 71.65 |
| High | 16.15 | 193.38 | 13.29 | 8.93 | 71.71 |
| Low | 15.34 | 191.64 | 12.99 | 8.65 | 71.19 |
| Last | 15.86 | 193.02 | 13.18 | 8.66 | 71.31 |
| Change | +0.31 | +0.03 | +0.09 | -0.08 | -0.30 |
| % Change | +1.96% | +0.02% | +0.69% | -0.92% | -0.42% |
| Volume | 26,574,100 | 12,442,600 | 6,571,600 | 2,199,100 | 141,800 |
| 20-Day Average Volume | 8,612,350 | 4,993,145 | 8,671,345 | 4,001,510 | 172,610 |
| Previous Close | 15.55 | 192.99 | 13.09 | 8.74 | 71.61 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | No | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.15 | 188.05 | 13.83 | 9.59 | 72.84 |
| 20-Day Raw Stochastic | 86.27% | 76.90% | 12.88% | 9.68% | 12.57% |
| 20-Day Relative Strength | 55.75% | 59.14% | 46.17% | 42.08% | 41.11% |
| Weighted Alpha | -23.10 | +28.20 | +63.41 | -0.72 | +16.12 |
| Today's Opinion | 40% Sell | 72% Buy | 56% Buy | 56% Buy | 24% Buy |
| Previous Opinion | 64% Sell | 56% Buy | 56% Buy | 56% Buy | 24% Buy |
| Last Month's Opinion | 64% Sell | 24% Sell | 88% Buy | 88% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.86% since 11/09/20 | +1.73% since 05/01/20 | -4.84% since 04/10/24 | -2.91% since 04/10/24 | -1.78% since 04/10/24 |
| Low | 15.10 on 11/10/20 | 187.75 on 05/04/20 | 12.99 on 04/17/24 | 8.36 on 04/11/24 | 70.86 on 04/15/24 |
| High | 16.15 on 11/16/20 | 196.45 on 05/06/20 | 13.99 on 04/11/24 | 9.87 on 04/11/24 | 73.16 on 04/11/24 |
| 1-Month | |||||
| %Chg | +0.92% since 10/16/20 | +6.59% since 04/08/20 | -1.86% since 03/15/24 | -5.87% since 03/15/24 | -5.22% since 03/15/24 |
| Low | 14.00 on 10/29/20 | 181.21 on 04/09/20 | 12.99 on 04/17/24 | 8.36 on 04/11/24 | 70.86 on 04/15/24 |
| High | 16.15 on 11/16/20 | 196.45 on 05/06/20 | 14.47 on 04/08/24 | 11.46 on 04/03/24 | 75.79 on 03/18/24 |
| 3-Month | |||||
| %Chg | -2.07% since 08/14/20 | -2.05% since 02/07/20 | +19.49% since 01/17/24 | +6.13% since 01/17/24 | +5.85% since 01/17/24 |
| Low | 14.00 on 10/29/20 | 158.67 on 03/18/20 | 10.86 on 01/19/24 | 7.68 on 02/05/24 | 67.35 on 01/22/24 |
| High | 17.03 on 08/19/20 | 202.21 on 02/12/20 | 14.47 on 04/08/24 | 11.46 on 04/03/24 | 77.72 on 02/23/24 |
| 6-Month | |||||
| %Chg | +4.58% since 05/15/20 | +6.48% since 11/08/19 | +52.19% since 10/17/23 | +11.45% since 10/17/23 | +7.52% since 10/17/23 |
| Low | 14.00 on 10/29/20 | 158.67 on 03/18/20 | 8.06 on 10/23/23 | 6.53 on 11/13/23 | 63.72 on 11/03/23 |
| High | 19.24 on 06/08/20 | 202.21 on 02/12/20 | 14.47 on 04/08/24 | 11.46 on 04/03/24 | 77.72 on 02/23/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,586,212 | 63,503,972 | 14,675,120 | 3,193,701 | 11,950,134 |
| Shares Outstanding, K | 541,546 | 329,002 | 1,121,094 | 365,412 | 166,878 |
| Annual Sales | 11,500,500,000 | 16,088,900,000 | 15,846,000,000 | 8,757,000,000 | 2,992,000,000 |
| Annual Net Income | 16,800,000 | -5,271,000,000 | -559,000,000 | -592,000,000 | 548,000,000 |
| Last Quarter Sales | 2,972,100,000 | 4,351,000,000 | 4,457,000,000 | 2,408,000,000 | 865,780,000 |
| Last Quarter Net Income | 185,700,000 | -317,200,000 | 429,000,000 | -39,000,000 | 165,470,000 |
| 60-Month Beta | 1.45 | 1.20 | 1.05 | 0.85 | 0.58 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.36 on 11/06/20 | 5.22 on 02/10/20 | 1.00 on 01/31/24 | 1.15 on 02/22/24 | 0.99 on 01/31/24 |
| Latest Earnings Date | 11/06/20 | 05/07/20 | 05/08/24 | 05/02/24 | 05/08/24 |
| Most Recent Dividend | 0.060 on 06/27/07 | 0.740 on 04/15/20 | 0.072 on 11/27/17 | 1.000 on 11/10/10 | 0.410 on 07/28/23 |
| Next Ex-Dividends Date | N/A | 04/15/20 | 11/27/17 | N/A | 07/28/23 |
| Ratios | |||||
| Price/Earnings ttm | 3.29 | 10.94 | 5.36 | 2.46 | 18.77 |